Timothy I. Still - 14 Oct 2025 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Oct 2025, 16:05:10 UTC
Prior SEC filing
10 Dec 2024
Next SEC filing
23 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Timothy I. Still

Key filing fact

Timothy I. Still filed Form 4 for VOLITIONRX LTD (VNRX) on 15 Oct 2025.

Key facts

  • This page summarizes Timothy I. Still's Form 4 filing for VOLITIONRX LTD (VNRX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 15 Oct 2025, 16:05.

Change

  • Previous filing in this sequence was filed on 10 Dec 2024.
  • Current net transaction value: +$25,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001200616 Primary reporting owner

STILL TIMOTHY I

Relationship
Director
Address
1489 WEST WARM SPRINGS ROAD,, SUITE 110, HENDERSON
Signature
/s/ Timothy I. Still
Signature date
15 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VNRX transaction

Common Stock

Purchase

Transaction value
$24,519
Shares
+48,076
Change %
+3.2%
Price
$0.5100
Shares after
1,535,458
Date
14 Oct 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VNRX transaction Derivative

Warrant (Right to Buy)

Purchase

Transaction value
$481
Shares
+48,076
Change %
Price
$0.0100*
Shares after
48,076
Date
14 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
48,076
Exercise price
$0.6000
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares of common stock and accompanying common stock warrants were purchased by the reporting person from the underwriter in connection with an underwritten public offering by the Issuer. The offering closed on October 14, 2025. The reported sale price reflects the price of $0.52 per share of common stock and accompanying warrant to purchase one additional share of common stock, of which $0.01 of the sale price was allocated to the warrant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .